Selank Deep Dive: Anxiolytic and Nootropic Mechanisms in Research
Research Use Only. This article is for scientific and educational reference only. All products are sold for research purposes and are not intended for human or animal consumption.
Overview
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a stabilized analogue of tuftsin, an endogenous tetrapeptide with immunomodulatory properties. Selank has been approved in Russia as an anxiolytic and nootropic drug (brand name Selank).
Mechanism of Action
Selank's mechanism is multifaceted and not fully elucidated, but key pathways include:
GABAergic modulation: Research has demonstrated that Selank modulates GABA-A receptor activity, similar to benzodiazepines but through a different binding site. This contributes to its anxiolytic effects without the sedation or dependence associated with classical benzodiazepines.
Serotonin system: Studies have shown that Selank increases serotonin metabolism in the brain, particularly in the hippocampus and frontal cortex.
BDNF upregulation: Selank has been shown to increase brain-derived neurotrophic factor (BDNF) expression, which supports neuroplasticity and cognitive function.
Enkephalin metabolism: Selank inhibits enkephalinase, the enzyme that degrades endogenous enkephalins (endorphin-like peptides), leading to increased enkephalin levels and reduced anxiety.
Immune modulation: As a tuftsin analogue, Selank retains immunomodulatory properties, including activation of macrophages and NK cells.
Anxiolytic Research
Comparison with benzodiazepines: Clinical trials in Russia compared Selank to phenazepam (a potent benzodiazepine) in generalized anxiety disorder. Selank demonstrated comparable anxiolytic efficacy with a superior side effect profile — specifically, no sedation, no cognitive impairment, and no dependence potential.
Mechanism vs. benzodiazepines: Unlike benzodiazepines that act as positive allosteric modulators at the GABA-A benzodiazepine binding site, Selank appears to act through a distinct mechanism, explaining its lack of tolerance and dependence.
Nootropic Research
Memory and learning: Animal studies have demonstrated that Selank improves performance on spatial memory tasks (Morris water maze) and associative learning paradigms.
Stress-induced cognitive impairment: Research has shown that Selank prevents stress-induced impairment of memory consolidation, suggesting neuroprotective effects under stress conditions.
BDNF and neuroplasticity: The BDNF-upregulating effects of Selank provide a mechanistic basis for its nootropic properties, as BDNF is critical for long-term potentiation (LTP) and memory formation.
Selank vs. Semax
| Parameter | Selank | Semax | |-----------|--------|-------| | Primary effect | Anxiolytic, anti-stress | Cognitive enhancement, neuroprotection | | BDNF effect | Moderate upregulation | Strong upregulation | | Anxiety | Reduces | Neutral to mild reduction | | Stimulant effect | None | Mild | | Administration | Intranasal | Intranasal | | Approval | Russia (anxiolytic) | Russia (nootropic) |
Clinical Trials
Selank has been evaluated in several Russian clinical trials:
- Generalized anxiety disorder: Demonstrated efficacy comparable to phenazepam with superior tolerability - Neurasthenia: Improved fatigue, cognitive function, and emotional stability - Alcohol withdrawal: Showed promise in reducing anxiety and improving sleep during alcohol withdrawal
Summary
Selank represents a unique class of anxiolytic peptide with a mechanism distinct from classical benzodiazepines. Its combination of anxiolytic, nootropic, and immunomodulatory effects, along with an absence of sedation or dependence potential, makes it a valuable research tool for studying anxiety neurobiology and cognitive function.
See Also: Semax Deep Dive: Cognitive Enhancement and Neuroprotection Research | Peptide Research Glossary: Key Terms and Definitions
Was this article helpful?
Click a star to rate